Gregory A. Gould
Chief Administration OfficerMr. Gregory A. Gould, also known as Greg, CPA, served as Chief Financial Officer of AJNA BioSciences PBC. He is Chief Financial Officer of Aclarion, Inc. from September 3, 2025. He had been Chief Financial Officer of NewAge, Inc. (formerly known as New Age Beverages Corporation) since October 2018 until July 02, 2021. Mr. Gould served as the Chief Financial Officer at Aytu BioScience, Inc. from June 2014 to November 15, 2017 and served as its Treasurer and Secretary since April 16, 2015 until November 2017 and Principal Accounting Officer. Mr. Gould served as Part time Chief Financial Officer of Aytu BioScience, Inc. since April 16, 2015 to June 16, 2017. He served as Chief Financial Officer, Treasurer and Corporate Secretary at Ampio Pharmaceuticals, Inc. since June 10, 2014 until June 10, 2017. He is a highly accomplished Financial Executive with expertise in the life sciences industry. Prior to joining Ampio, Mr. Gould provided financial and operational consulting services to the biotech industry through his consulting company, Gould LLC from April 2012 to June 2014. He served as the Chief Financial Officer of Luoxis and Vyrix in June 2014. He served as the Chief Financial Officer at Rosewind Corp., since April 16, 2015. He has also held CFO roles at 7 publicly-traded companies, including Charlottes Web. He served as Interim Chief Executive Officer and Interim President of SeraCare Life Sciences, Inc. from July 2011 to April 2012. He served as the Chief Financial Officer and Treasurer of SeraCare Life Sciences, Inc. from August 2006 to April 2012. He served as Secretary of SeraCare Life Sciences, Inc. from November 2006 to April 2012 and also served as its Principal Accounting Officer. Prior to his time at SeraCare, he served as the Chief Financial Officer at Atrix Laboratories, Inc. in Fort Collins, Colorado. During Mr. Gould’s tenure at Atrix, he was instrumental in the negotiation and sale of it to QLT, Inc. He played a critical role in the management of several licensing agreements including the global licensing agreement with Sanofi-Synthelabo of the Eligard® products. He served as Principal Accounting Officer of Aytu BioScience, Inc. He has held several other executive positions at publicly traded life sciences companies. He served as a Consultant of Integrated Biopharma Inc. from August 2005 to August 2006. He served as Senior Vice President and Chief Financial Officer of Integrated Biopharma Inc. from April 26, 2005 to August 9, 2005. Mr. Gould served as the Chief Financial Officer of TOLMAR Therapeutics, Inc. since February 5, 2004 and served as its Secretary, Treasurer and Principal Accounting Officer until November 2004. During his tenure with TOLMAR Therapeutics, Inc., he developed and implemented several strategic and financial business improvements. Mr. Gould served as Chief Financial Officer of Therapure—Products (Evolve Biologics), a subsidiary of Therapure BioPharma, Inc., from November 2017 until October 2018. Before joining TOLMAR Therapeutics, Inc., Mr. Gould served as Chief Financial Officer and Treasurer of Colorado MEDTEC LLC (CMED), where he negotiated the transaction to sell it to KRG Capital Partners. since August 2000. From February 1996 to October 2003, he served as Director of Finance of Colorado MEDTEC LLC. During his tenure with CMED, he was a Leader in financial management, developing and implementing several strategic and financial business transactions. Prior to his time at CMED, Mr. Gould served as an Accountant with Arthur Andersen LLP in Denver, Colorado, from August 1990 to February 1996. He began his career as an Auditor with Arthur Andersen, LLP. He served as the Chairman of Cytodyn Inc. from July 25, 2012 to June 17, 2013. He served as an Independent Director of CytoDyn Inc., since March 30, 2006 until August 12, 2019. He is a Certified Public Accountant in the state of Colorado and a Member of the Colorado Society of Certified Public Accountants. Mr. Gould earned a B.S in Business Administration from the University of Colorado, Boulder in 1989.
公司职务
- 公司名称Charlotte's Web Holdings, Inc.股票代码CWBHF职务Chief Administration Officer共事同僚
- WJWilliam J. MorachnickCEO & Non-Independent Director
- AMAngela May McElweeIndependent Chairman of the Board
- ELErika LindCFO & Principal Accounting Officer
- RKRaymond KunkelChief Operating Officer
- MBMarcel Bonn-MillerChief Scientific Officer
- GAGregory A. GouldChief Administration Officer
- MEMatthew E. McCarthyIndependent Director
- MKMaureen K. UsiferIndependent Director
- MBM. Borgia WalkerDirector
- 公司名称Aclarion, Inc.股票代码ACON职务Chief Financial Officer
